You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 1, January 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, NEW ORLEANS, MAY 22 TO MAY 25, 1988-Pa rt I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Photodynamic Therapy for Esophageal Tumors

James S. McCaughan, Jr, MD; Thomas A. Nims, MD; Jerry T. Guy, MD; William J. Hicks, MD; Thomas E. Williams, Jr, MD; Leslie R. Laufman, MD

Arch Surg. 1989;124(1):74-80.


Abstract

• Between 1982 and 1987, 40 patients with esophageal tumors (19 adenocarcinomas, 19 squamous carcinomas, and two melanomas) in whom conventional treatments were unsuccessful were treated with photodynamic therapy (PDT) after injection with either hematoporphyrin derivative or dihematoporphyrin ether. Patients underwent endoscopy again two to three days and one month after PDT and as needed when symptoms recurred. At one month, the average minimal diameter opening of 28 assessable tumors increased from 6 to 9 mm. Of the 35 patients who could be evaluated one month after PDT, the average improvement in food intake was from a liquid to a soft diet. Average survival time (from time of first treatment) was 7.7 months (n=17) for adenocarcinoma, 5.8 months (n=12) for squamous cell carcinoma, and 25 months (n=2) for melanoma. Two patients with stage I adenocarcinoma were alive with no evidence of disease at 11 and 23 months. One patient with stage I squamous cell cancer died 18 months after PDT, with recurrence of tumor above the treated area noted eight months after treatment. One patient with stage I melanoma died of a synchronous colon cancer 31 months after PDT, with no evidence of residual melanoma.

(Arch Surg 1989;124:74-80)



Author Affiliations

From the Departments of Surgery (Drs McCaughan, Nims, and Williams) and Medical Oncology (Drs Guy, Hicks, and Laufman), Grant Medical Center, Columbus, Ohio.


Footnotes

Accepted for publication Sept 2, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 23, 1988.

Reprint requests to Laser Medical Research Foundation, 323 E Town St, Columbus, OH 43215 (Dr McCaughan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The role of photodynamic therapy (PDT) in inoperable oesophageal cancer
Moghissi et al.
Eur. J. Cardiothorac. Surg. 2000;17:95-100.
ABSTRACT | FULL TEXT  

Primary Malignant Melanoma of the Esophagus
Joob et al.
Ann. Thorac. Surg. 1995;60:217-222.
ABSTRACT | FULL TEXT  

Photodynamic Therapy to Treat Tumors of the Extrahepatic Biliary Ducts: A Case Report
McCaughan et al.
Arch Surg 1991;126:111-113.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.